Create issue ticket

11,035 Possible Causes for defines

  • Upper Respiratory Infection

    Recurrent febrile URI and exacerbations were defined as two or more episodes within the previous 6 months.[] URI episodes were defined by a symptom criterion and by clinically verified self-reported illness.[] Additional studies are needed to further define the role of acute phase cytokines in virus-induced AOM.[]

  • Urinary Tract Infection

    Participants will receive either a defined daily dose of 3   2 arbutin 105 mg for 5 days (intervention) or fosfomycin 3 g once (control).[] Symptoms that all studies considered were relevant to diagnose UTI were adequately defined.[] Ultrasonography revealed multiple, ill-defined margined, hypoechoic areas and cysts within the cortex.[]

  • Acute Gastroenteritis

    The rotavirus and norovirus epidemic periods were defined as the periods from March to June and from November to February, respectively, based on their disease prevalence.[] AGE was defined by a medical question (Do you have a stomach or intestinal illness with vomiting or diarrhea that started during last 30 d?).[] METHODS: The probable cases and confirmed cases were defined as students or teachers with diarrhoea or vomiting present since the term began in February 2014.[]

  • Influenza

    However, pregnancy-induced shifts in vaccine responsiveness remain poorly defined.[] The seroprotection rate was defined in 2 ways as the proportion of subjects who achieved an antibody titer of 1:40 or 1:160.[] The 2013, 2014 and 2015 seasonal influenza vaccines produced by Instituto Butantan were safe and immunogenic according to the immunogenicity criteria defined by the European[]

  • Patulous Eustachian Tube

    METHODS: Studies evaluating the surgical management of PET were extracted based on defined inclusion criteria.[] The classification for grading of severity is defined as follows: 1) no handicap (0-8), 2) mild handicap (10-16), 3) moderate handicap (18-24), and 4) severe handicap (26-[] Successful treatment was defined as complete relief or significant improvement plus satisfaction with treatment.[]

  • Sinusitis

    RESULTS AND CONCLUSIONS: NLD enlargement, defined as a truly isolated asymptomatic dilatation of the NLD, is rarely encountered.[] Importance is placed on following a systematic process of investigation and management, and adhering to well-defined basic surgical principles.[] Aspirin-exacerbated respiratory disease (AERD) is defined as asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase-1 inhibitors.[]

  • Skin Infection

    Abstract Disseminated herpes zoster is defined as the presence of more than 20 lesions outside the dermatome.[] OBJECTIVES: Outcome assessments as clinical trial endpoints should be well-defined, reliable, and reflect meaningful treatment benefits.[] .” — Tony Allen still thinks about a defining moment in his career that happened in Boston.[]

  • Dementia

    He had no opportunistic infections or any other AIDS defining illnesses. He recovered fully within 3 months of antiretroviral therapy.[] Among the risk factors evaluated in the BHT, a total risk score greater or equal to 8 was defined as a high risk for dementia.[] INTERVENTIONS: Daily defined doses of anticholinergic drugs coded using the Anticholinergic Cognitive Burden (ACB) scale, in total and grouped by subclass, prescribed 4-20[]

  • Pneumonia

    VAP-TF was defined as composite of death attributable to pneumonia and relapse within 28 days of the first episode.[] The primary endpoint was adverse outcome defined as death or ICU admission within 30-days; the secondary endpoint was 6-year mortality.[] Patients suspected of having VAP by the clinical team underwent bronchoscopic bronchoalveolar lavage (bBAL) and semi-quantitative culture, with VAP defined as clinical symptoms[]

  • Acute Bronchitis

    MAIN OUTCOME MEASURE: The primary study end point was clinical cure, as defined by a or 75% reduction in a validated Acute Bronchitis Severity Score by 14 days; analysis was[] The main outcome measure is the number of days with frequent cough defined by the symptom diary with a score of 1 or more.[] Cochrane Database of Systematic Reviews 2004, Issue 4 Efficacy Endpoints: Clinical improvement or cure Harm Endpoints: Reduction in cough Narrative: Acute bronchitis is defined[]

Further symptoms